Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The effect of flexible assertive community treatment in Denmark: a quasi-experimental controlled study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A large-scale genome-wide association study meta-analysis of cannabis use disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cannabidiol for cannabis use disorder: too high hopes?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Discontinuation of antipsychotic medication-time to rethink trial design

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. How mental health care should change as a consequence of the COVID-19 pandemic

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Dysregulated Lipid Metabolism Precedes Onset of Psychosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Assessment of Suicidal Behaviors Among Individuals With Autism Spectrum Disorder in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association between neonatal homecare for preterm infants and incidence of severe postpartum depression in mothers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Danish premature birth rates during the COVID-19 lockdown

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Although the pathogenic nature of copy number variants (CNVs) on chromosome 22q11.2 has been recognised for decades, unbiased estimates of their population prevalence, mortality, disease risks, and diagnostic trajectories are absent. We aimed to provide the true population prevalence of 22q11.2 CNVs and associated trajectory of disease risk and mortality by use of the unbiased, representative Danish iPSYCH population case cohort.

METHODS: This case-cohort study was done on a population of 86 189 individuals selected from the iPSYCH case cohort of 1 472 762 singletons born in Denmark between May 1, 1981, and Dec 31, 2005, who have a known mother from the Danish Civil Registration System, were residents in Denmark at 1 year of age, and enrolled in the iPSYCH Initiative. We used epidemiological methods in conjunction with nationwide hospital registers to analyse the iPSYCH case cohort of individuals with attention-deficit hyperactivity disorder (ADHD), major depressive disorder, schizophrenia, autism, or bipolar disorder and a random population-based sample. The main outcomes assessed were the population prevalence of 22q11.2 rearrangements, and associated unbiased, population-adjusted estimates and 31-year disease risk trajectories for major neuropsychiatric disorders.

FINDINGS: Population prevalence in the Danish population was one in 3672 (seven of 25 704 [0·027%; 95% CI 0·012-0·057]) for deletions and one in 1606 (17 of 25 704 [0·066%; 0·040-0·107]) for duplications. Mortality after the age of 1 year among carriers was zero, and hazard ratios for neuropsychiatric disorders ranged from 2·60 to 82·44 for both rearrangements. By the age of 32 years, about 10% of individuals with deletions or duplications had developed ADHD, autism, or intellectual disability, and deletion carriers had higher probability than duplication carriers of co-occurring intellectual disability or epilepsy.

INTERPRETATION: The significantly different prevalence of 22q11.2 duplications and deletions indicates distinct selective pressures on these rearrangements. Although risk of congenital abnormalities, developmental delay, and intellectual disability is elevated in deletion carriers, the overall prevalence of neuropsychiatric disorders is higher in duplication carriers, which implies that identification and clinical monitoring should extend beyond congenital traits and into child and adolescent psychiatry.

FUNDING: Capital Region's Research Foundation for Mental Health Research, The Lundbeck Foundation, and US National Institutes of Health.

OriginalsprogEngelsk
TidsskriftThe Lancet. Psychiatry
Vol/bind5
Udgave nummer7
Sider (fra-til)573-580
Antal sider8
ISSN2215-0366
DOI
StatusUdgivet - jul. 2018

ID: 55039678